Literature DB >> 19135280

Risk of thromboembolism varies, depending on category of immobility in outpatients.

Daren M Beam1, D Mark Courtney, Christopher Kabrhel, Christopher L Moore, Peter B Richman, Jeffrey A Kline.   

Abstract

STUDY
OBJECTIVE: Immobility predisposes to venous thromboembolism, but this risk may vary, depending on the underlying cause of immobility.
METHODS: This was a prospective, longitudinal outcome study of self-presenting emergency department (ED) patients who were from 12 hospitals and had suspected venous thromboembolism. Using explicit written criteria, clinicians recorded clinical features of each patient in the ED by using a Web-based data form. The form required one of 6 types of immobility: no immobility, general or whole-body immobility greater than 48 hours, limb (orthopedic) immobility, travel greater than 8 hours causing immobility within the previous 7 days, neurologic paralysis, or other immobility not listed above. Patients were followed for 45 days for outcome of venous thromboembolism, which required positive imaging results and clinical plan to treat. Odds ratios (ORs) were derived from logistic regression including 12 covariates.
RESULTS: From 7,940 patients enrolled, 545 of 7,940 (6.9%) were diagnosed with venous thromboembolism (354 pulmonary embolism, 72 deep venous thrombosis, 119 pulmonary embolism and deep venous thrombosis). Risk of venous thromboembolism varied, depending on immobility type: limb (OR=2.24; 95% confidence interval [CI] 1.40 to 3.60), general (OR=1.76; 95% CI 1.26 to 2.44), other (OR=1.97; 95% CI 1.25 to 3.09), neurologic (OR=2.23; 95% CI 1.01 to 4.92), and travel (OR=1.19; 95% CI 0.85 to 1.67). Other significant risk factors from multivariate analysis included age greater than 50 years (OR =1.5; 95% CI 1.25 to 1.82), unilateral leg swelling (OR=2.68; 95% CI 2.13 to 3.37), previous venous thromboembolism (OR=2.99; 95% CI 2.41 to 3.71), active malignancy (OR=2.23; 95% CI 1.69 to 2.95), and recent surgery (OR=2.12; 95% CI 1.61 to 2.81).
CONCLUSION: In a large cohort of symptomatic ED patients, risk of venous thromboembolism was substantially increased by presence of limb, whole-body, or neurologic immobility but not by travel greater than 8 hours. These data show the importance of clarifying the cause of immobility in risk assessment of venous thromboembolism.

Entities:  

Mesh:

Year:  2009        PMID: 19135280     DOI: 10.1016/j.annemergmed.2008.10.033

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  10 in total

1.  Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism.

Authors:  Christopher Kabrhel; D Mark Courtney; Carlos A Camargo; Michael C Plewa; Kristen E Nordenholz; Christopher L Moore; Peter B Richman; Howard A Smithline; Daren M Beam; Jeffrey A Kline
Journal:  Acad Emerg Med       Date:  2010-06       Impact factor: 3.451

Review 2.  Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism.

Authors:  Meredith Turetz; Andrew T Sideris; Oren A Friedman; Nidhi Triphathi; James M Horowitz
Journal:  Semin Intervent Radiol       Date:  2018-06-04       Impact factor: 1.513

3.  Travel-Associated Venous Thromboembolism.

Authors:  Isla McKerrow Johnson; Joseph Shatzel; Sven Olson; Tovah Kohl; Andrew Hamilton; Thomas G DeLoughery
Journal:  Wilderness Environ Med       Date:  2022-03-31       Impact factor: 1.479

4.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

Authors:  Holger J Schünemann; Mary Cushman; Allison E Burnett; Susan R Kahn; Jan Beyer-Westendorf; Frederick A Spencer; Suely M Rezende; Neil A Zakai; Kenneth A Bauer; Francesco Dentali; Jill Lansing; Sara Balduzzi; Andrea Darzi; Gian Paolo Morgano; Ignacio Neumann; Robby Nieuwlaat; Juan J Yepes-Nuñez; Yuan Zhang; Wojtek Wiercioch
Journal:  Blood Adv       Date:  2018-11-27

5.  Venous thromboembolism in amyotrophic lateral sclerosis: a prospective study.

Authors:  Matthew Gladman; Melanie Dehaan; Hanika Pinto; William Geerts; Lorne Zinman
Journal:  Neurology       Date:  2014-04-11       Impact factor: 9.910

6.  Hypoxia Induces a Prothrombotic State Independently of the Physical Activity.

Authors:  Marisa Ninivaggi; Marieke de Laat; Marcus M D Lancé; Cécile H Kicken; Leonie Pelkmans; Saartje Bloemen; Marlou L Dirks; Luc J C van Loon; José W P Govers-Riemslag; Theo Lindhout; Joke Konings; Bas de Laat
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

7.  Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.

Authors:  Ludvig B Rinde; Birgit Småbrekke; Ellisiv B Mathiesen; Maja-Lisa Løchen; Inger Njølstad; Erin M Hald; Tom Wilsgaard; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  J Am Heart Assoc       Date:  2016-11-07       Impact factor: 5.501

8.  Venous Thromboembolism Following Dantrolene Treatment for Neuroleptic Malignant Syndrome.

Authors:  Po-Hao Chen; Hsien-Yuan Lane; Chieh-Hsin Lin
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-11-30       Impact factor: 2.582

9.  Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Patients, Single-Center, Prospective, Open-Label, Single-Arm Clinical Trial, Long-Term Follow-up.

Authors:  Seyed Massood Nabavi; S Hahedeh Karimi; Leila Arab; Leila Sanjari; Soura Mardpour; Vajiheh Azimian; Neda Jarughi; Azadeh Ghaheri; Seyedeh-Esmat Hosseini; Nasser Aghdami; Massoud Vosough
Journal:  Cell J       Date:  2021-12-29       Impact factor: 2.479

Review 10.  Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients.

Authors:  Daniel Corrigan; Christiana Prucnal; Christopher Kabrhel
Journal:  Clin Exp Emerg Med       Date:  2016-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.